Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma × Tomography, Optical Coherence × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 3 Pancreatic Neoplasms 2 Urinary Bladder Neoplasms 1 Telangiectasis 1 Skin Neoplasms 1 Rosacea 1 Prostatic Neoplasms 1 Precancerous Conditions 1 Port-Wine Stain 1 Pancreatic Intraductal Neoplasms 1 Non-melanoma Skin Cancer 1 Nevus, Pigmented 1 Mixed Tumor, Malignant 1 Melanoma 1 Lung Neoplasms 1 Keratosis, Seborrheic 1 Keratosis 1 Hemangioma 1 Glioma 1 Carcinoma, Transitional Cell 1 Carcinoma 1 Barrett Esophagus 1

Interventions

Cisplatin 45 Carboplatin 39 pembrolizumab 37 Paclitaxel 33 Gemcitabine 27 Radiotherapy 18 Pemetrexed 18 Magnetic Resonance Spectroscopy 18 Radiotherapy, Intensity-Modulated 17 Docetaxel 16 Specimen Handling 15 Cetuximab 15 Nivolumab 14 Fluorouracil 13 Cyclophosphamide 13 durvalumab 12 130-nm albumin-bound paclitaxel 10 Platinum 9 osimertinib 8 Sunitinib 8 Sorafenib 8 Radiation 8 Oxaliplatin 8 Bevacizumab 8 1,2-diaminocyclohexaneplatinum II citrate 8 Irinotecan 7 Everolimus 7 Drug Therapy 7 Capecitabine 7 fludarabine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02851693 2019-04-04

OCTSKIN

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Withdrawn

Carcinoma, Keratosis, Mixed Tumor, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡